NCT06870487 2026-02-19A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled
NCT06484816 2025-02-24TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic MalignanciesShenzhen TargetRx, Inc.Phase 1 Recruiting90 enrolled
NCT04537715 2025-02-19Effects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsIpsenPhase 1 Completed42 enrolled 39 charts
NCT02663518 2024-05-10A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsPfizerPhase 1 Terminated249 enrolled 43 charts
NCT04272203 2022-09-08A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated CancersAbbViePhase 1 Terminated14 enrolled
NCT02706392 2022-08-31Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesFred Hutchinson Cancer CenterPhase 1 Terminated21 enrolled 19 charts
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled